• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    12.96 Down 0.17(1.29%) 4:00PM EDT
    |After Hours : 12.96 0.00 (0.00%) 4:24PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 4,363   4,356   160,639   -  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,363   4,356   160,639   -  
    Operating Expenses
    Research Development88,428  36,082  44,895  28,165  
    Selling General and Administrative8,550  7,382  8,042  7,057  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (92,615) (39,108) 107,702   (35,222)
    Income from Continuing Operations
    Total Other Income/Expenses Net(40)(17)52  136  
    Earnings Before Interest And Taxes(92,655)(39,125)107,754  (35,086)
    Interest Expense647  1,034  4,538  2,938  
    Income Before Tax(93,302)(40,159)103,216  (38,024)
    Income Tax Expense -  183   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(93,302)(40,342)103,216  (38,024)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (93,302) (40,342) 103,216   (38,024)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (93,302) (40,342) 103,216   (38,024)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.